Home / Peptides / BPC-157

BPC-157 Dosage: What the Evidence Says (2026)

Not FDA-approved

15-amino-acid peptide studied mostly in animals. Not approved; no established human dose.

Also called: Body Protection Compound 157, PL 14736, bepecin

Regulatory status (US)

Not approved by the FDA for any use. FDA removed it from its "significant safety risk" compounding list in April 2026 after the nomination was withdrawn, and an FDA advisory committee voted in favor of allowing pharmacy compounding in July 2026, against the recommendation of FDA staff. On October 30, 2026, HHS published a draft policy saying it does not intend to take enforcement action against state-licensed pharmacies that compound it for a named patient with a prescription, under listed conditions and routes. That is not an FDA approval and says nothing about safety or effectiveness. The draft policy names the acetate form for injection under the skin or into muscle, oral and topical use.

What it is

A synthetic 15-amino-acid peptide based on a sequence from a stomach protein. Proposed effects on healing and blood vessel growth come mainly from animal studies.

Dosage

No established human dose. No FDA label or published dose-finding trial gives a dose for BPC-157. Numbers you see on seller sites or forums are not based on reviewed human studies, so we do not list them.

BPC-157 reconstitution calculator

Enter your vial and your prescribed dose to see the units on a U-100 syringe.

–
Concentration–
Per 1 unit (0.01 mL)–
Volume per dose–
Doses per vial–

What human studies show

Safety

Questions

Is BPC-157 FDA-approved?
Not approved by the FDA for any use. FDA removed it from its "significant safety risk" compounding list in April 2026 after the nomination was withdrawn, and an FDA advisory committee voted in favor of allowing pharmacy compounding in July 2026, against the recommendation of FDA staff. On October 30, 2026, HHS published a draft policy saying it does not intend to take enforcement action against state-licensed pharmacies that compound it for a named patient with a prescription, under listed conditions and routes. That is not an FDA approval and says nothing about safety or effectiveness. The draft policy names the acetate form for injection under the skin or into muscle, oral and topical use.
What dose of BPC-157 has been studied?
There is no established human dose. No dose-finding trial in humans has been published. Early ulcerative colitis studies (enema, 2003-2005) were only published as abstracts. A 2025 safety pilot gave it by IV to 2 healthy adults; no side effects were reported. Two people cannot establish safety. FDA reviewers cited signals of clotting and liver effects in repeat-dose animal studies.
How many units is my BPC-157 dose?
Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.

Related

Sermorelin

The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.

TB-500 (thymosin beta-4)

Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.

GHK-Cu (copper peptide)

Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.

KLOW and GLOW blends

Seller-defined mixes of GHK-Cu, BPC-157, TB-500 (GLOW) plus KPV (KLOW). No human data for any blend.

Sources

  1. FDA: Certain bulk drug substances for compounding that may present significant safety risks
  2. Federal Register (public inspection) 2026-07361: peptide category changes
  3. PharmExec: FDA advisory committee votes to loosen restrictions on peptides (Jul 2026)
  4. Federal Register 2026-22192: HHS draft enforcement discretion policy for 503A compounding of certain peptides (Oct 30, 2026)
  5. Venable LLP: HHS announces interim enforcement discretion for certain peptides (Nov 2026)
  6. Lee & Burgess 2025: IV BPC-157 safety pilot in two adults (PubMed)
  7. FDA 510(k) K212499: BD insulin syringes for U-100 insulin

Last checked 2026-11-16. How we pick and check sources: methodology.